Important advances in Parkinson disease (PD) in 2015 included a revision of its clinical diagnostic criteria and a proposal for research criteria defining prodromal PD. Research published in the past year has also continued to expand our understanding of the roles of Lewy pathology and α-synuclein in the pathobiology of PD.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Association of accelerometer-measured physical activity intensity, sedentary time, and exercise time with incident Parkinson’s disease
npj Digital Medicine Open Access 28 November 2023
-
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
Neurological Sciences Open Access 09 September 2023
-
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Biomaterials Research Open Access 16 May 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kalia, L. V. & Lang, A. E. Parkinson's disease. Lancet 386, 896–912 (2015).
Berg, D. et al. MDS research criteria for prodromal Parkinson's disease. Mov. Disord. 30, 1600–1611 (2015).
Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord. 30, 1591–1601 (2015).
Schrag, A., Horsfall, L., Walters, K., Noyce, A. & Petersen, I. Prediagnostic presentations of Parkinson's disease in primary care: a case–control study. Lancet Neurol. 14, 57–64 (2015).
Dijkstra, A. A. et al. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease. Mov. Disord. 29, 1244–1251 (2014).
Iacono, D. et al. Parkinson disease and incidental Lewy body disease: just a question of time? Neurology 85, 1670–1679 (2015).
Kalia, L. V. et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 72, 100–105 (2015).
Peelaerts, W. et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340–344 (2015).
Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain. Brain 138, 1642–1657 (2015).
Svensson, E. et al. Vagotomy and subsequent risk of Parkinson's disease. Ann. Neurol. 78, 522–529 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kalia, L., Lang, A. Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol 12, 65–66 (2016). https://doi.org/10.1038/nrneurol.2015.249
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.249
This article is cited by
-
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
Neurological Sciences (2024)
-
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Biomaterials Research (2023)
-
Association of accelerometer-measured physical activity intensity, sedentary time, and exercise time with incident Parkinson’s disease
npj Digital Medicine (2023)
-
Recent advances in nanotechnology and its application for neuro-disease: a review
Applied Nanoscience (2023)
-
Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease
Cell Death & Differentiation (2022)
